Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002545)

(Analysis AN004192)

Metabolite	Structure	F1	F2
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)	ME617076	1.44	0.50
PC(40:4)	ME617157	1.27	0.73
18:1 Cholesteryl ester;	ME617054	1.21	0.79
SM(d34:1)	ME617197	1.20	0.80
PC(40:5) B	ME617159	1.17	0.83
SM(d34:0)	ME617196	1.19	0.81
PC(40:6)B	ME617161	1.18	0.82
SM(d36:1)	ME617200	1.18	0.82
LPC (20:0)	ME617081	0.57	1.43
TG(56:2)	ME617253	0.79	1.21
TG(53:3)	ME617244	0.79	1.21
PC(p-40:6)/PC(o-40:7) B	ME617182	0.79	1.21
PC(p-38:5)/PC(o-38:6) B	ME617176	0.79	1.21
PC(37:6)	ME617144	0.79	1.21
acylcarnitine(18:1)	ME617064	0.79	1.21
LPC(20:4)	ME617098	0.79	1.21
TG 56:5; TG(18:2/18:2/20:1);	ME617223	0.80	1.20
PC(40:8)	ME617164	0.80	1.20
LPC (22:6)	ME617085	0.80	1.20
LPE(20:4)	ME617103	0.80	1.20
PC(p-40:4)/PC(o-40:5)	ME617179	0.77	1.23
LPC(18:3)	ME617096	0.77	1.23
PC(34:3) C	ME617125	0.77	1.23
TG(53:4)	ME617245	0.78	1.22
SM(d41:2) A	ME617210	0.78	1.22
TG(51:4)	ME617240	0.78	1.22
TG(49:1)	ME617232	0.81	1.19
TG(48:4) A	ME617231	0.81	1.19
PC(p-38:3)/PC(o-38:4) A	ME617172	0.81	1.19
PC(38:1)	ME617145	0.81	1.19
PC(34:4)	ME617126	0.81	1.19
LPC(18:1)	ME617094	0.81	1.19
PC(32:2)	ME617116	0.81	1.19
TG(58:8)	ME617267	0.82	1.18
PC(37:4)	ME617143	0.82	1.18
PE(p-36:2)/PE(o-36:3)	ME617189	0.82	1.18
TG 54:4; TG(18:1/18:1/18:2);	ME617219	0.84	1.16
SM (d39:2)	ME617193	0.84	1.16
acylcarnitine(14:1)	ME617061	0.84	1.16
acylcarnitine(14:2)	ME617062	0.84	1.16
TG 58:10; TG(18:2/20:4/20:4);	ME617224	0.83	1.17
TG(54:7) A	ME617250	0.83	1.17
TG(54:2)	ME617247	0.83	1.17
TG(48:1)	ME617228	0.83	1.17
PC(p-40:5)/PC(o-40:6)	ME617180	0.83	1.17
LPE(18:2)	ME617102	0.83	1.17
PC(36:4) A	ME617136	0.83	1.17
PC(39:4)	ME617156	0.70	1.30
LPC (17:1)	ME617080	0.69	1.31
LPC (20:1)	ME617082	0.68	1.32
TG(56:9)	ME617261	0.65	1.35
PC(p-36:4)/PC(o-36:5)	ME617171	0.67	1.33
PC(34:3) A	ME617123	0.67	1.33
PC(34:3) B	ME617124	0.67	1.33
PC(37:2)	ME617142	0.66	1.34
SM(d40:2) A	ME617207	0.66	1.34
TG 56:4; TG(18:1/18:2/20:1);	ME617222	0.76	1.24
TG(54:8)	ME617251	0.76	1.24
PC(p-40:6)/PC(o-40:7) A	ME617181	0.76	1.24
PC(p-38:5)/PC(o-38:6) A	ME617175	0.76	1.24
PC(42:10)	ME617165	0.76	1.24
PC(33:2)	ME617119	0.76	1.24
acylcarnitine(18:2)	ME617065	0.76	1.24
LPC(20:3)	ME617097	0.76	1.24
TG(56:4)	ME617255	0.75	1.25
TG 53:5; TG(17:1/18:2/18:2);	ME617217	0.75	1.25
TG(51:3)	ME617239	0.75	1.25
TG(51:2)	ME617238	0.75	1.25
TG(48:2)	ME617229	0.75	1.25
PC(40:7) A	ME617162	0.75	1.25
Cer(d40:1)	ME617066	0.75	1.25
PC(38:7)	ME617155	0.75	1.25
PC(35:3)	ME617130	0.74	1.26
DG(36:3)	ME617073	0.74	1.26
LPC(15:0)	ME617090	0.74	1.26
TG(50:3) A	ME617235	0.73	1.27
PC(p-38:6)/PC(o-38:7)	ME617177	0.73	1.27
PC(38:6) A	ME617153	0.73	1.27
PC(38:2)	ME617146	0.73	1.27
PC(35:2) A	ME617128	0.73	1.27
LPC(16:1)	ME617092	0.73	1.27
PC(33:1)	ME617118	0.73	1.27
TG(48:3)	ME617230	0.72	1.28
SM(d40:2) B	ME617208	0.72	1.28
SM(d39:1)	ME617204	0.72	1.28
GlcCer(d40:1)	ME617077	0.72	1.28
PC(36:3) B	ME617135	0.72	1.28
TG(56:3)	ME617254	0.71	1.29
PC(p-34:2)/PC(o-34:3)	ME617169	0.71	1.29
PC(35:4)	ME617131	0.71	1.29
PC(36:5) C	ME617139	0.71	1.29
TG(50:2)	ME617234	0.86	1.14
PC(36:5)A	ME617141	0.86	1.14
PC(32:1)	ME617115	0.86	1.14
PC(36:4) C	ME617138	0.86	1.14
TG 60:12; TG(18:2/20:4/22:6);	ME617227	0.85	1.15
TG(56:5) A	ME617256	0.85	1.15
PC (42:5)	ME617106	0.85	1.15
PC (p-36:3) or PC (o-36:4)	ME617109	0.85	1.15
TG 58:7; TG(18:1/18:2/22:4);	ME617226	0.89	1.11
TG(58:2)	ME617264	0.89	1.11
LPC(18:2)	ME617095	0.89	1.11
TG(52:4)	ME617243	0.89	1.11
TG(56:1)	ME617252	0.87	1.13
PC(p-42:5)/PC(o-42:6) A	ME617184	0.87	1.13
PC(38:4) A	ME617148	0.87	1.13
DG(36:4) A	ME617074	0.87	1.13
acylcarnitine (16:0)	ME617060	0.87	1.13
Cer(d42:2) A	ME617069	0.87	1.13
TG(58:6)	ME617266	0.88	1.12
TG(58:3)	ME617265	0.88	1.12
TG 58:11; TG(18:2/20:4/20:5);	ME617225	0.88	1.12
TG(56:7) B	ME617260	0.88	1.12
TG(54:1)	ME617246	0.88	1.12
TG(51:1)	ME617237	0.88	1.12
SM(d40:1)	ME617206	0.88	1.12
PC(p-34:1)/PC(o-34:2)	ME617168	0.88	1.12
PC(36:5) D	ME617140	0.88	1.12
PC(35:1)	ME617127	0.88	1.12
DG(38:6)	ME617075	0.88	1.12
PC(33:0)	ME617117	0.88	1.12
TG(54:6) B	ME617249	0.92	1.08
SM(d41:2)B	ME617211	0.92	1.08
SM(d38:2)	ME617203	0.92	1.08
SM(d34:2)	ME617198	0.92	1.08
PC(p-38:4)/PC(o-38:5) A	ME617174	0.92	1.08
PC(p-38:3)/PC(o-38:4) B	ME617173	0.92	1.08
PC (p-32:0) or PC (o-32:1)	ME617108	0.92	1.08
PC 40:9;	ME617111	0.92	1.08
LPC (o-16:0)	ME617086	0.92	1.08
PC(31:0)	ME617113	0.92	1.08
TG(58:1)	ME617262	0.90	1.08
TG(60:4)	ME617271	0.91	1.09
TG(60:3)	ME617270	0.91	1.09
TG 54:5; TG(18:0/18:2/18:3);	ME617220	0.91	1.09
LPC (p-16:0) or LPC (o-16:1)	ME617087	0.91	1.09
PE(38:6)	ME617188	0.91	1.09
SM(d42:3)	ME617214	0.90	1.09
TG 52:3; TG(16:0/18:1/18:2);	ME617216	0.90	1.10
PC(p-42:5)/PC(o-42:6) B	ME617185	0.90	1.10
PC(p-40:3)/PC(o-40:4)	ME617178	0.90	1.10
LPC(14:0)	ME617089	0.90	1.10
PC(35:2) B	ME617129	0.90	1.10
TG(60:2)	ME617269	0.94	1.01
TG(62:4)	ME617273	0.94	1.06
TG(62:3)	ME617272	0.94	1.06
TG 54:3; TG(18:0/18:1/18:2);	ME617218	0.94	1.06
TG(52:1)	ME617241	0.94	1.06
SM (d37:1)	ME617192	0.94	1.06
PC(38:6) B	ME617154	0.94	1.06
LPC (20:2)	ME617083	0.94	1.06
Cer(d42:2) B	ME617070	0.94	1.06
DG(34:2)	ME617072	0.94	1.06
PC(p-42:4)/PC(o-42:5)	ME617183	0.93	1.07
PC(p-36:1)/PC(o-36:2) A	ME617170	0.93	1.07
PC(p-32:1)/PC(o-32:2)	ME617167	0.93	1.07
PC(34:1)	ME617121	0.93	1.07
PC(36:3) A	ME617134	0.93	1.07
TG(59:3)	ME617268	0.97	1.03
SM(d33:1)	ME617195	0.97	1.03
LPC (p-18:0) or LPC (o-18:1)	ME617088	0.97	1.03
PC (p-38:2) or PC (o-38:3)	ME617110	0.97	1.03
TG(56:7) A	ME617259	0.95	1.05
TG(52:3)	ME617242	0.95	1.05
PC(o-32:0)	ME617166	0.95	1.05
PC(40:7) B	ME617163	0.95	1.05
PC (37:3)	ME617104	0.95	1.05
PC(36:4) B	ME617137	0.95	1.05
LPC(16:0)	ME617091	0.95	1.05
18:2 Cholesteryl ester;	ME617055	0.95	1.05
Cer(d42:1)	ME617068	0.95	1.05
TG 52:2; TG(16:0/18:1/18:1);	ME617215	0.96	1.04
PE(36:2)	ME617186	0.96	1.04
PC (39:6)	ME617105	0.96	1.04
PC(38:5) A	ME617151	0.96	1.04
PC(34:2)	ME617122	0.96	1.04
LPC(20:5)	ME617099	0.96	1.04
Cholesteryl ester(18:3)	ME617059	0.96	1.04
20:4 Cholesteryl ester;	ME617056	0.96	1.04
acylcarnitine(18:0)	ME617063	0.96	1.04
PC(30:0)	ME617112	1.14	0.86
TG(58:10)	ME617263	1.08	0.92
SM(d32:1)	ME617194	1.08	0.92
SM(d42:1)	ME617212	1.08	0.92
SM(d42:2)	ME617213	1.09	0.91
SM(d40:0)	ME617205	1.09	0.91
SM(d41:1)	ME617209	1.09	0.91
PE(p-38:5)/PE(o-38:6)	ME617191	1.12	0.88
PC(40:5) A	ME617158	1.10	0.90
PE(38:4)	ME617187	1.11	0.89
PC(36:2)	ME617133	1.00	1.00
PC(38:3)	ME617147	1.00	1.00
TG(50:1)	ME617233	1.00	0.99
SM(d36:2)	ME617201	1.01	0.99
22:6 Cholesteryl ester;	ME617057	1.01	0.99
Cholesterol	ME617071	1.01	0.99
Cer(d41:1)	ME617067	0.98	1.02
LPC (22:4)	ME617084	0.98	1.02
TG 54:7; TG(18:2/18:2/18:3);	ME617221	0.99	1.01
TG(54:5) B	ME617248	0.99	1.01
TG(50:5)	ME617236	0.99	1.01
GlcCer(d42:1)	ME617078	0.99	1.01
GlcCer(d42:2)	ME617079	0.99	1.01
PE(p-36:4)/PE(o-36:5)	ME617190	1.05	0.95
PC (42:6)	ME617107	1.05	0.95
PC(32:0)	ME617114	1.05	0.95
PC(34:0)	ME617120	1.05	0.95
SM(d36:0)	ME617199	1.07	0.93
PC(40:6) A	ME617160	1.06	0.94
PC(38:5) B	ME617152	1.06	0.94
PC(38:4) B	ME617149	1.06	0.94
LPC(18:0)	ME617093	1.06	0.94
LPE(18:0)	ME617101	1.06	0.94
TG(56:5) B	ME617257	1.02	0.98
TG(56:6)	ME617258	1.02	0.98
SM(d38:1)	ME617202	1.04	0.96
PC(38:4) C	ME617150	1.03	0.97
PC(36:1)	ME617132	1.03	0.97
Cholesteryl ester(16:1)	ME617058	1.03	0.97
LPC(22:5)	ME617100	1.03	0.97

Factors:

F1	Factor:Infected
F2	Factor:Uninfected

Data matrix